These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14980648)

  • 41. Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.
    Wilson LJ; Wang B; Yang SM; Scannevin RH; Burke SL; Karnachi P; Rhodes KJ; Murray WV
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6485-90. PubMed ID: 21925881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.
    Chen MH; Cui SX; Cheng YN; Sun LR; Li QB; Xu WF; Ward SG; Tang W; Qu XJ
    Anticancer Drugs; 2008 Nov; 19(10):957-65. PubMed ID: 18827560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In situ "click" assembly of small molecule matrix metalloprotease inhibitors containing zinc-chelating groups.
    Hu M; Li J; Yao SQ
    Org Lett; 2008 Dec; 10(24):5529-31. PubMed ID: 19053720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural basis for the highly selective inhibition of MMP-13.
    Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU
    Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereoselectivity by enantiomeric inhibitors of matrix metalloproteinase-8: new insights from molecular dynamics simulations.
    Aschi M; Besker N; Re N; Pochetti G; Coletti C; Gallina C; Mazza F
    J Med Chem; 2007 Jan; 50(2):211-8. PubMed ID: 17228863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2).
    Rossello A; Nuti E; Orlandini E; Carelli P; Rapposelli S; Macchia M; Minutolo F; Carbonaro L; Albini A; Benelli R; Cercignani G; Murphy G; Balsamo A
    Bioorg Med Chem; 2004 May; 12(9):2441-50. PubMed ID: 15080939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice.
    Lorenzl S; Narr S; Angele B; Krell HW; Gregorio J; Kiaei M; Pfister HW; Beal MF
    Exp Neurol; 2006 Jul; 200(1):166-71. PubMed ID: 16516196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Matrix metalloproteinases and their inhibitors in malignant and autoreactive pericardial effusion.
    Lamparter S; Schoppet M; Christ M; Pankuweit S; Maisch B
    Am J Cardiol; 2005 May; 95(9):1065-9. PubMed ID: 15842972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.
    O'Brien PM; Ortwine DF; Pavlovsky AG; Picard JA; Sliskovic DR; Roth BD; Dyer RD; Johnson LL; Man CF; Hallak H
    J Med Chem; 2000 Jan; 43(2):156-66. PubMed ID: 10649971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula.
    Shorey S; Heersche JN; Manolson MF
    Bone; 2004 Oct; 35(4):909-17. PubMed ID: 15454098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and characterization of a metalloproteinase inhibitor-tethered resin for the detection of active MMPs in biological samples.
    Hesek D; Toth M; Meroueh SO; Brown S; Zhao H; Sakr W; Fridman R; Mobashery S
    Chem Biol; 2006 Apr; 13(4):379-86. PubMed ID: 16632250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury.
    Fligiel SE; Standiford T; Fligiel HM; Tashkin D; Strieter RM; Warner RL; Johnson KJ; Varani J
    Hum Pathol; 2006 Apr; 37(4):422-30. PubMed ID: 16564916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigating chelating sulfonamides and their use in metalloproteinase inhibitors.
    Tanakit A; Rouffet M; Martin DP; Cohen SM
    Dalton Trans; 2012 Jun; 41(21):6507-15. PubMed ID: 22411188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. From sensors to silencers: quinoline- and benzimidazole-sulfonamides as inhibitors for zinc proteases.
    Rouffet M; de Oliveira CA; Udi Y; Agrawal A; Sagi I; McCammon JA; Cohen SM
    J Am Chem Soc; 2010 Jun; 132(24):8232-3. PubMed ID: 20507095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
    Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G
    J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.
    Cuniasse P; Devel L; Makaritis A; Beau F; Georgiadis D; Matziari M; Yiotakis A; Dive V
    Biochimie; 2005; 87(3-4):393-402. PubMed ID: 15781327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure.
    Moe GW; Laurent G; Doumanovskaia L; Konig A; Hu X; Dorian P
    J Card Fail; 2008 Nov; 14(9):768-76. PubMed ID: 18995182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Eur J Med Chem; 2008 Oct; 43(10):2130-9. PubMed ID: 18362041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic potential of sulfamides as enzyme inhibitors.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Med Res Rev; 2006 Nov; 26(6):767-92. PubMed ID: 16710859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.